Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HIV-Associated Cancers and Related Diseases
Robert Yarchoan, Thomas S. Uldrick
New England Journal of Medicine (2018) Vol. 378, Iss. 11, pp. 1029-1041
Open Access | Times Cited: 434

Showing 1-25 of 434 citing articles:

Kaposi sarcoma
Ethel Cesarman, Blossom Damania, Susan E. Krown, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 544
The clinical progress of mRNA vaccines and immunotherapies
Ann Barbier, Allen Yujie Jiang, Peng Zhang, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 6, pp. 840-854
Open Access | Times Cited: 501
The mutual interplay of gut microbiota, diet and human disease
Placido Illiano, Roberta Brambilla, Cinzia Parolini
FEBS Journal (2020) Vol. 287, Iss. 5, pp. 833-855
Open Access | Times Cited: 271
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study
Thomas S. Uldrick, Priscila Gonçalves, Maher Abdul‐Hay, et al.
JAMA Oncology (2019) Vol. 5, Iss. 9, pp. 1332-1332
Open Access | Times Cited: 201
Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer
Michael R. Cook, Chul Kim
JAMA Oncology (2019) Vol. 5, Iss. 7, pp. 1049-1049
Closed Access | Times Cited: 187
Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)
Célèste Lebbe, Claus Garbe, Alexander J. Stratigos, et al.
European Journal of Cancer (2019) Vol. 114, pp. 117-127
Open Access | Times Cited: 185
Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations
Jordi Remón, Francesco Passiglia, Myung‐Ju Ahn, et al.
Journal of Thoracic Oncology (2020) Vol. 15, Iss. 6, pp. 914-947
Open Access | Times Cited: 140
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
Jason D. Goldman, Philip C. Robinson, Thomas S. Uldrick, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 6, pp. e002630-e002630
Open Access | Times Cited: 107
A temporal perspective for tumor-associated macrophage identities and functions
Camille Blériot, Garett Dunsmore, Direna Alonso‐Curbelo, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 747-758
Closed Access | Times Cited: 24
Skin Cancer and Immunosuppression
Lindsey Collins, Andrew Quinn, Thomas Stasko
Dermatologic Clinics (2018) Vol. 37, Iss. 1, pp. 83-94
Closed Access | Times Cited: 148
Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
Neil J. Shah, Ghassan Al‐Shbool, Matthew Blackburn, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 107
Sex Hormones and Anticancer Immunity
Berna C. Özdemir, G. Paolo Dotto
Clinical Cancer Research (2019) Vol. 25, Iss. 15, pp. 4603-4610
Open Access | Times Cited: 105
Biology and management of primary effusion lymphoma
Kazuyuki Shimada, Fumihiko Hayakawa, Hitoshi Kiyoi
Blood (2018) Vol. 132, Iss. 18, pp. 1879-1888
Open Access | Times Cited: 93
Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers
David Egg, Charlotte Schwab, Annemarie Gabrysch, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 88
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
Nazzarena Labò, Hidetaka Ohnuki, Giovanna Tosato
Cells (2020) Vol. 9, Iss. 7, pp. 1583-1583
Open Access | Times Cited: 86
Point-of-Care Digital Cytology With Artificial Intelligence for Cervical Cancer Screening in a Resource-Limited Setting
Oscar Holmström, Nina Linder, Harrison Kaingu, et al.
JAMA Network Open (2021) Vol. 4, Iss. 3, pp. e211740-e211740
Open Access | Times Cited: 86
Hematologic cancers in individuals infected by HIV
Antonino Carbone, Emanuela Vaccher, Annunziata Gloghini
Blood (2021) Vol. 139, Iss. 7, pp. 995-1012
Open Access | Times Cited: 83
Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome‐driven neoplasms
Tsuyoshi Hamada, Jonathan A. Nowak, Danny A. Milner, et al.
The Journal of Pathology (2019) Vol. 247, Iss. 5, pp. 615-628
Open Access | Times Cited: 81
Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions
Jérôme Kervevan, Lisa A. Chakrabarti
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 523-523
Open Access | Times Cited: 63
The effect of non-AIDS-defining cancers on people living with HIV
Elizabeth Y. Chiao, Anna E. Coghill, Darya Kizub, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 6, pp. e240-e253
Open Access | Times Cited: 59
4′-Modified Nucleosides for Antiviral Drug Discovery: Achievements and Perspectives
Junbiao Chang
Accounts of Chemical Research (2022) Vol. 55, Iss. 4, pp. 565-578
Closed Access | Times Cited: 52
Roles and mechanisms of the m6A reader YTHDC1 in biological processes and diseases
Huaqing Yan, Liqi Zhang, Xiaobo Cui, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 48
HIV/AIDS Associated Lymphoma: Review
Ayenew Berhan, Biruk Bayleyegn, Zegeye Getaneh
Blood and Lymphatic Cancer Targets and Therapy (2022) Vol. Volume 12, pp. 31-45
Open Access | Times Cited: 46
KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine
Corey Casper, Lawrence Corey, Jeffrey I. Cohen, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 45
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
Talal El Zarif, Amin H. Nassar, Elio Adib, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 21, pp. 3712-3723
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top